Pharmaceutical Technology Europe E-Alert

Pharmaceutical Technology E-Alert: Having trouble viewing this e-mail? Click here.	You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

BLOG

EVENT CALENDAR

COLUMNS

WHITE PAPERS

THE MAGAZINE

Pharmaceutical Technology Europe E-Alert

04 June 2010

IN THIS ISSUE
• PTE Digital June issue
• Tabletting issues
• Avoiding common problems
• Top technologies
• More...



The present and the future of tabletting technologies Industry experts discuss some of the tabletting technology breakthroughs that the pharma industry has witnessed in recent years, and offer insight into market trends, changing demands and how the challenges to good and consistent tabletting can be overcome. More...

Tabletting: the issues facing today’s manufacturers Find out what PTE readers feel are the most common problems encountered with their tabletting equipment. More...

Tabletting equipment: common problems and how to avoid them The most common causes of tabletting equipment problems and malfunctions is misuse or improper handling and transportation, which often leads to accidental damage to tablet punches, including nicks and dents to the punch tip edges. More...

Tabletting equipment product showcase A range of some of the top tabletting technologies available on the European market. More...



FDA testifies regarding J&J recalls The FDA has testified before the US House Committee on Oversight and Government Reform about J&J’s recall of certain medications for children, and has also expressed quality concerns regarding the company’s McNeil Consumer Healthcare division. More...

EMA database aids safety monitoring A study conducted by the European Medicines Agency (EMA) has shown that statistical methods using the EMA’s EudraVigilance database of adverse drug reaction reports can be used to detect drug safety issues “significantly earlier” compared with routine pharmacovigilance. More...

Hearings held on the benefits and risks of synthetic biology The US House of Representatives has held hearings to gain testimony on the potential benefits and risks associated with synthetic biology and synthetic genomics. More...

*Join PTE* on LinkedIn!** Join Pharmaceutical Technology Europe's group on LinkedIn. More...

Podcast

Vetter

The North American market is critical to Vetter’s strategic global growth as nearly half of its client base is already located here. In order to maximize on this opportunity, Vetter has decided to create a facility, its first outside of Germany, at the Illinois Science + Technology Park in suburban Chicago.

Read more...

Product Profiles

Agilent

June 9-10
Messe Berlin, Germany

After the success of Chemspec Europe in Barcelona, Berlin is a natural choice as the destination for Chemspec Europe 2010. Germany is at the heart of the European fine and speciality chemicals market and the third largest chemical producer in the world making it an ideal destination for Chemspec Europe to celebrate its 25th anniversary.

Read more...

Gen-Probe

Shimadzu

Veltek

To encourage innovation in excipients, do you think FDA should review novel excipients outside of a new drug application?

■		RFID 10%
■		Barcoding 26%
■		On-dose technologies 7%
■		Tamper-evident packaging 19%
■		Other 12%
■		None 26%

This week we would like to know...

Which anti counterfeiting solution is your company currently using?

Contact Us
Click here to contact editorial.

Click here to contact sales.

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail at Advanstar Communications Inc., Advanstar House, Park West, Sealand Road, Chester, CH1 4RN United Kingdom